Khaled Khazim

SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA

Pantelis Sarafidis, Charles J. Ferro, Enrique Morales et al. · Nephrology Dialysis Transplantation · 2019 · 204 citations

Medicine, Endocrinology, Pharmacology +17

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Targeting NADPH oxidase with a novel dual Nox1/Nox4 inhibitor attenuates renal pathology in type 1 diabetes

Yves Gorin, Rita C. Cavaglieri, Khaled Khazim et al. · American Journal of Physiology-Renal Physiology · 2015 · 182 citations · Full text

Medicine, Biochemistry, Nephrology +17

Sestrin 2 and AMPK Connect Hyperglycemia to Nox4-Dependent Endothelial Nitric Oxide Synthase Uncoupling and Matrix Protein Expression

Assaad A. Eid, Doug-Yoon Lee, Linda J. Roman et al. · Molecular and Cellular Biology · 2013 · 136 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

The antioxidant silybin prevents high glucose-induced oxidative stress and podocyte injury in vitro and in vivo

Khaled Khazim, Yves Gorin, Rita C. Cavaglieri et al. · American Journal of Physiology-Renal Physiology · 2013 · 123 citations

Medicine, Biochemistry, Physiology +17